Abstract:Author summaryBy focusing on Hypophosphatasia, a rare inherited disorder we performed a comprehensive computational analysis of mutational effects on protein function in the encoded protein of Tissue Nonspecific Alkaline Phosphatase. This analysis demonstrated that pathogenic mutations can often modulate long-range allosteric interactions and communications in the dynamic protein network and the mechanisms underlying severity of mutational effects can be rationalized based on molecular principles of allostery. We have also developed a machine learning-based method to classify different disease phenotypes, and the interpretability of the classification model was addressed using the structural-functional analysis of network topologically important mutations. The results of this study revealed allosteric molecular signatures of severe mutations, suggesting that allosteric models of protein dynamics and function can be useful in dissecting complex genotype-phenotype relationships. Hypophosphatasia (HPP) is a rare inherited disorder characterized by defective bone mineralization and is highly variable in its clinical phenotype. The disease occurs due to various loss-of-function mutations in ALPL, the gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). In this work, a data-driven and biophysics-based approach is proposed for the large-scale analysis of ALPL mutations-from nonpathogenic to severe HPPs. By using a pipeline of synergistic approaches including sequence-structure analysis, network modeling, elastic network models and atomistic simulations, we characterized allosteric signatures and effects of the ALPL mutations on protein dynamics and function. Statistical analysis of molecular features computed for the ALPL mutations showed a significant difference between the control, mild and severe HPP phenotypes. Molecular dynamics simulations coupled with protein structure network analysis were employed to analyze the effect of single-residue variation on conformational dynamics of TNSALP dimers, and the developed machine learning model suggested that the topological network parameters could serve as a robust indicator of severe mutations. The results indicated that the severity of disease-associated mutations is often linked with mutation-induced modulation of allosteric communications in the protein. This study suggested that ALPL mutations associated with mild and more severe HPPs can exert markedly distinct effects on the protein stability and long-range network communications. By linking the disease phenotypes with dynamic and allosteric molecular signatures, the proposed integrative computational approach enabled to characterize and quantify the allosteric effects of ALPL mutations and role of allostery in the pathogenesis of HPPs.

Ionomycin Ameliorates Hypophosphatasia Via Rescuing Alkaline Phosphatase Deficiency-Mediated L-type Ca2+ Channel Internalization in Mesenchymal Stem Cells

ALPL regulates pro-angiogenic capacity of mesenchymal stem cells through ATP-P2X7 axis controlled exosomes secretion

Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia.

One Patient with Perinatal Hypophosphatasia Due to Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene

Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model

GSK3β rephosphorylation rescues ALPL deficiency-induced impairment of odontoblastic differentiation of DPSCs

GSK3β Rephosphorylation&nbsp;Rescues ALPL&nbsp;Deficiency Induced-impairment of Odontoblastic Differentiation of DPSCs

Dissecting mutational allosteric effects in alkaline phosphatases associated with different Hypophosphatasia phenotypes: An integrative computational investigation

Tissue Nonspecific Alkaline Phosphatase (TNAP) Regulates Cranial Base Growth and Synchondrosis Maturation

Clinical and Genetic Characteristics of Hypophosphatasia in Chinese Adults.

The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase

Clinical, pathological and genetic evaluations of Chinese patients with autosomal-dominant hypophosphatasia

Enzyme replacement therapy on hypophosphatasia mouse model

Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene

A Novel Missense Mutation in the Alpl Gene Causes Dysfunction of the Protein

Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

Six ALPL gene variants in five children with hypophosphatasia

Adult hypophosphatasia caused by ALPL mutation: one pedigree study

Identification of the mutations in the tissue-nonspecific alkaline phosphatase gene in two Chinese families with hypophosphatasia.

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia

Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review